Primary glomerular disease associated with high cardiovascular disease risk

Published On 2022-06-06 04:30 GMT   |   Update On 2022-06-07 10:08 GMT

It is a known fact that patients with chronic kidney disease are known to be at high risk of cardiovascular disease. Cardiovascular risk in patients with primary glomerular diseases is poorly understood because these conditions are rare and require a kidney biopsy for diagnosis.Very little is known about the risk of cardiovascular disease (CVD) in such patients. Hence, in a...

Login or Register to read the full article

It is a known fact that patients with chronic kidney disease are known to be at high risk of cardiovascular disease. Cardiovascular risk in patients with primary glomerular diseases is poorly understood because these conditions are rare and require a kidney biopsy for diagnosis.

Very little is known about the risk of cardiovascular disease (CVD) in such patients. Hence, in a population-based study on adults with primary glomerular disease, researchers described the risk of cardiovascular disease compared to the general population and also studied the impact of traditional and kidney-related risk factors on cardiovascular disease risk.

Study is published in the American Journal of Kidney Diseases (AJKD). Here the rate of cardiovascular events in 1,912 Canadian patients with biopsy-proven IgA nephropathy, minimal change disease, and membranous nephropathy was 2.5 times as high as the general population and was high for each disease type.

Consideration of disease type, kidney function, and proteinuria improved the prediction of cardiovascular events. Therefore, to summarise, this population-level study showed that patients with primary glomerular diseases have a high cardiovascular risk, and that inclusion of kidney-specific risk factors may improve risk stratification.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News